|
RICTOR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.822700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.342200E-02 |
| Normal-vs-Stage2 |
6.680200E-01 |
| Normal-vs-Stage3 |
4.570600E-04 |
| Normal-vs-Stage4 |
2.03919999999247E-05 |
| Stage1-vs-Stage2 |
4.898400E-01 |
| Stage1-vs-Stage3 |
4.558300E-02 |
| Stage1-vs-Stage4 |
4.683700E-03 |
| Stage2-vs-Stage3 |
1.143360E-01 |
| Stage2-vs-Stage4 |
5.261800E-02 |
| Stage3-vs-Stage4 |
4.606600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.842300E-03 |
| Normal-vs-AfricanAmerican |
2.785600E-04 |
| Normal-vs-Asian |
8.217600E-01 |
| Caucasian-vs-AfricanAmerican |
5.092300E-02 |
| Caucasian-vs-Asian |
5.305600E-01 |
| AfricanAmerican-vs-Asian |
1.073370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.256300E-03 |
| Normal-vs-Female |
8.619500E-03 |
| Male-vs-Female |
8.662000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.022900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.859500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.060700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.106240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.860600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.561700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.981800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.869800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.082600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.734600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.880400E-01 |
| Normal-vs-Grade 2 |
2.003000E-01 |
| Normal-vs-Grade 3 |
6.413200E-04 |
| Normal-vs-Grade 4 |
3.72989999997131E-08 |
| Grade 1-vs-Grade 2 |
9.183400E-01 |
| Grade 1-vs-Grade 3 |
2.460200E-01 |
| Grade 1-vs-Grade 4 |
5.923000E-03 |
| Grade 2-vs-Grade 3 |
1.871530E-02 |
| Grade 2-vs-Grade 4 |
1.70629999995953E-06 |
| Grade 3-vs-Grade 4 |
2.618000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.931600E-01 |
| Normal-vs-ccB subtype |
3.162700E-03 |
| ccA subtype-vs-ccB subtype |
5.082700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.828100E-02 |
| Normal-vs-N1 |
5.900900E-03 |
| N0-vs-N1 |
6.937500E-02 |
|
|
